Background Whey proteins have insulinogenic properties and the effect appears to originate from a specific postprandial plasma amino acid pattern. The insulinogenic effect can be mimicked by a specific mixture of the five amino acids iso, leu, lys, thr and val. Objective The objective was to evaluate the efficacy of pre-meal boluses of whey or soy protein with or without added amino acids on glycaemia, insulinemia as well as on plasma responses of incretins and amino acids at a subsequent composite meal. Additionally, plasma ghrelin and subjective appetite responses were studied. Design In randomized order, fourteen healthy volunteers were served a standardized composite ham sandwich meal with either water provided (250 ml) during the time course of the meal, or different pre-meal protein drinks (PMPD) (100 ml provided as a bolus) with additional water (150 ml) served to the meal. The PMPDs contained 9 g protein and were based on either whey or soy protein isolates, with or without addition of the five amino acids (iso, leu, lys, thr and val) or the five amino acids + arg. Results All PMPD meals significantly reduced incremental area for plasma glucose response (iAUC) during the first 60 min. All whey based PMPD meals displayed lower glycemic indices compared to the reference meal. There were no significant differences for the insulinemic indices. The early insulin response (iAUC 0–15 min) correlated positively to plasma amino acids, GIP and GLP-1 as well as to the glycemic profile. Additionally, inverse correlations were found between insulin iAUC 0–15 min and the glucose peak. Conclusion The data suggests that a pre-meal drink containing specific proteins/amino acids significantly reduces postprandial glycemia following a composite meal, in absence of elevated insulinemic excursions. An early phase insulinemic response induced by plasma amino acids and incretins appears to mediate the effect. Trial Registration ClinicalTrials.gov NCT01586780
References
[1]
Ceriello A, Colagiuri S, Gerich J, Tuomilehto J (2008) Guideline Development G (2008) Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis 18: S17–33.
[2]
Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F (2005) Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. American Journal of Clinical Nutrition 82: 523–530.
[3]
Malik VS, Sun Q, van Dam RM, Rimm EB, Willett WC, et al. (2011) Adolescent dairy product consumption and risk of type 2 diabetes in middle-aged women. American Journal of Clinical Nutrition 94: 854–861.
[4]
Warensjo E, Nolan D, Tapsell L (2010) Dairy Food Consumption and Obesity-Related Chronic Disease. In: Steve LT, editor. Advances in Food and Nutrition Research: Academic Press. 1–41.
[5]
Ruidavets JB, Bongard V, Dallongeville J, Arveiler D, Ducimetiere P, et al. (2007) High consumptions of grain, fish, dairy products and combinations of these are associated with a low prevalence of metabolic syndrome. Journal of Epidemiology and Community Health 61: 810–817.
[6]
Pfeuffer M, Schrezenmeir J (2007) Milk and the metabolic syndrome. Obes Rev 8: 109–118.
[7]
Luhovyy BL, Akhavan T, Anderson GH (2007) Whey proteins in the regulation of food intake and satiety. Journal of the American College of Nutrition 26: 704S–712S.
[8]
Jauhiainen T, Korpela R (2007) Milk peptides and blood pressure. the Journal of Nutrition 137: 825S–829S.
[9]
Frid AH, Nilsson M, Holst JJ, Bjorck IM (2005) Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. American Journal of Clinical Nutrition 82: 69–75.
[10]
Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM (2004) Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. American Journal of Clinical Nutrition 80: 1246–1253.
[11]
Nilsson M, Holst JJ, Bjorck IME (2007) Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. American Journal of Clinical Nutrition 85: 996–1004.
[12]
Noguchi Y, Nishikata N, Shikata N, Kimura Y, Aleman JO, et al. (2010) Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice. PLoS One 5: e12057.
[13]
Lucotti P, Monti L, Setola E, La Canna G, Castiglioni A, et al. (2009) Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism 58: 1270–1276.
[14]
van Loon LJ, Saris WH, Verhagen H, Wagenmakers AJ (2000) Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. American Journal of Clinical Nutrition 72: 96–105.
[15]
Velasquez MT, Bhathena SJ (2007) Role of dietary soy protein in obesity. Int J Med Sci 4: 72–82.
[16]
Veldhorst M, Nieuwenhuizen A, Hochstenbach-Waelen A, Westerterp K, Engelen M, et al. (2009) Effects of high and normal soyprotein breakfasts on satiety and subsequent energy intake, including amino acid and ‘satiety’ hormone responses. European Journal of Nutrition 48: 92–100.
[17]
Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, et al. (1983) Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. Journal of Clinical Endocrinology and Metabolism 56: 1306–1312.
[18]
Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43: 535–539.
[19]
Rosen LA, Silva LO, Andersson UK, Holm C, Ostman EM, et al. (2009) Endosperm and whole grain rye breads are characterized by low post-prandial insulin response and a beneficial blood glucose profile. Nutr J 8: 42.
[20]
Orskov C, Wettergren A, Holst JJ (1996) Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scandinavian Journal of Gastroenterology 31: 665–670.
[21]
Graf S, Egert S, Heer M (2011) Effects of whey protein supplements on metabolism: evidence from human intervention studies. Curr Opin Clin Nutr Metab Care 14: 569–580.
[22]
Gannon MC, Nuttall FQ (2010) Amino acid ingestion and glucose metabolism–a review. IUBMB Life 62: 660–668.
[23]
Pfeifer MA, Halter JB, Porte D (1981) Insulin secretion in diabetes mellitus. The American Journal of Medicine 70: 579–588.
[24]
Festa A, Williams K, Hanley AJ, Haffner SM (2008) Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57: 1638–1644.
[25]
Solerte SB, Fioravanti M, Locatelli E, Bonacasa R, Zamboni M, et al. (2008) Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus. American Journal of Cardiology 101: 82E–88E.
[26]
Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, et al. (2008) Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. American Journal of Cardiology 101: 69E–77E.
[27]
Ronner P, Naumann CM, Friel E (2001) Effects of glucose and amino acids on free ADP in betaHC9 insulin-secreting cells. Diabetes 50: 291–300.
[28]
van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, et al. (2003) Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26: 625–630.
[29]
Tahrani AA, Piya MK, Kennedy A, Barnett AH (2010) Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacology and Therapeutics 125: 328–361.
[30]
Valerio A, D’Antona G, Nisoli E (2011) Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective. Aging (Albany NY) 3: 464–478.
[31]
Delzenne N, Blundell J, Brouns F, Cunningham K, De Graaf K, et al. (2010) Gastrointestinal targets of appetite regulation in humans. Obes Rev 11: 234–250.
[32]
Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiological Reviews 87: 1409–1439.
[33]
Nauck M, Stockmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diab tologia 29: 46–52.
[34]
Holst JJ, Vilsboll T, Deacon CF (2009) The incretin system and its role in type 2 diabetes mellitus. Molecular and Cellular Endocrinology 297: 127–136.
[35]
Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, et al.. (2011) Glucagon-like peptide analogues for type 2 diabetes mellitus. Cochrane Database Syst Rev: CD006423.
[36]
Flatt PR, Kwasowski P, Howland RJ, Bailey CJ (1991) Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycemic (ob/ob) mice. the Journal of Nutrition 121: 1123–1128.
[37]
Thomas FB, Sinar D, Mazzaferri EL, Cataland S, Mekhjian HS, et al. (1978) Selective release of gastric inhibitory polypeptide by intraduodenal amino acid perfusion in man. Gastroenterology 74: 1261–1265.
[38]
Salehi AS, Gunnerud UJ, J MS, ？stman EM, Holst JJ, et al.. (2012) The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on beta-cells. Nutrition and Metabolism: in press.
[39]
Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131–2157.
[40]
Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, et al. (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diab tologia 47: 1403–1410.
[41]
Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, et al. (2006) Inflammatory process in type 2 diabetes: The role of cytokines. Annals of the New York Academy of Sciences 1084: 89–117.
[42]
Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, et al. (2011) Dietary factors and low-grade inflammation in relation to overweight and obesity. British Journal of Nutrition 106 Suppl 3S5–78.
[43]
Dickinson S, Hancock DP, Petocz P, Ceriello A, Brand-Miller J (2008) High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. American Journal of Clinical Nutrition 87: 1188–1193.
[44]
Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A, van Vught AJ, Westerterp KR, et al. (2009) Dose-dependent satiating effect of whey relative to casein or soy. Physiology and Behavior 96: 675–682.
[45]
Anderson GH, Moore SE (2004) Dietary proteins in the regulation of food intake and body weight in humans. the Journal of Nutrition 134: 974S–979S.
[46]
Gregersen S, Rasmussen O, Winther E, Hermansen K (1990) Water volume and consumption time: influence on the glycemic and insulinemic responses in non-insulin-dependent diabetic subjects. American Journal of Clinical Nutrition 52: 515–518.
